Therapeutic potentiation of combined cis-dichlorodiammineplatinum (II) and irradiation by ICRF-159.
D000818:Animals; D002453:Cell Cycle / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects; D002945:Cisplatin / Q000008:administration & dosage*; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy; D008297:Male; D051379:Mice; D009374:Neoplasms, Experimental / Q000628:therapy; D010879:Piperazines / Q000008:administration & dosage*; D011838:Radiation-Sensitizing Agents; D011929:Razoxane / Q000008:administration & dosage*; D013997:Time Factors
D010879:Piperazines; D011838:Radiation-Sensitizing Agents; D011929:Razoxane; D002945:Cisplatin